Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus

Virology

Volumn 269, Issue 2, 2000, Pages 257-267

  Tsukamoto, Kenji ^a   Sato, Takanori ^b   Saito, Shuji ^b   Tanimura, Nobuhiko ^a   Hamazaki, Naoki ^a   Mase, Masaji ^a   Yamaguchi, Shigeo ^a  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b ZEON CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANTIBODY TITER; ARTICLE; BIRD DISEASE; BIRNAVIRIDAE; CHICKEN; HISTOPATHOLOGY; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALIA; AVES; BIRNAVIRIDAE; FOWLPOX VIRUS; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 0034630466     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0184     Document Type: Article

References (36)

1. Azad A. A., Mckem N. M., Macreadie I. G., Failla P., Heine H. G., Chapman A., Fahey K. J. Physiochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine. 9:1991;715-722.
2. Bayliss C. D., Petres R. W., Cook J. K., Reece R. L., Howes K., Binns M. M., Boursnell M. E. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 120:1991;193-205.
3. Becht H., Müller H., Müller H. K. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J. Gen. Virol. 69:1988;631-640.
4. Bumstead N., Reece R. L., Cook J. K. A. Genetic differences in susceptibility of chicken lines to infectious bursal disease virus. Poult. Sci. 72:1993;403-410.
5. Calnek B. W., Witter R. L. Marek's disease. Calnek B. W., Barnes B. W., Beard C. W., McDougald L. R., Saif Y. M. Diseases of Poultry. 1997;369-413 Iowa State Univ. Press, Ames.
6. Cantello J. L., Anderson A. S., Francesconi A., Morgan R. W. Isolation of a Marek's Disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene. J. Virol. 65:1991;1584-1588.
7. Darteil R., Bublot M., Laplace E., Bouquet J.-F., Audonnet J.-C., Riviere M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology. 211:1995;481-490.
8. Fahey K. J., Erny K., Crooks J. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J. Gen. Virol. 70:1989;1473-1481.
9. Fahey K. J., McWaters P., Brown M. A., Erny K., Murphy V. J., Hewish D. R. Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Dis. 35:1991;365-373.
10. Fernandez-Arias A., Martinez S., Rodriguez J. F. The major antigenic protein of infectious bursal disease virus, VP2, is an apoptotic inducer. J. Virol. 71:1997;8014-8018.
11. Heckert R. A., Riva J., Cook S., McMillen J., Schwartz R. D. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis. 40:1996;770-777.
12. Heine H. G., Boyle D. B. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol. 131:1993;277-292.
13. Ismail N. M., Saif Y. M. Immunogenicity of infectious bursal disease viruses in chickens. Avian Dis. 35:1991;460-469.
14. Kent S. J., Zhao A., Best S. J., Chandler J. D., Boyle D. B., Ramshaw I. A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:1998;10180-10188.
15. Kibenge F. S. B., Dhillon A. S., Russell R. G. Biochemistry and immunology of infectious bursal disease virus. J. Gen. Virol. 69:1988;1757-1775.
16. Lukert P. D., Saif Y. M. Infectious bursal disease. Calnek B. W., Barnes B. W., Beard C. W., McDougald L. R., Saif Y. M. Diseases of Poultry. 1997;721-738 Iowa State Univ. Press, Ames.
17. Mazariegos L. A., Lukert P. D., Brown J. Pathogenicity and immunosuppressive properties of infectious bursal disease "intermediate" strain. Avian Dis. 34:1990;203-208.
18. Morgan R. W., Gelb J. Jr., Schreurs C. S., Lütticken D., Rosenberger J. K., Sondermeijer P. J. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 36:1992;858-870.
19. Morgan R. W., Gelb J. Jr., Pope C. R., Sondermeijer P. J. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies. Avian Dis. 37:1993;1032-1040.
20. Mundt E., Kollner B., Kretzschmar D. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J. Virol. 71:1997;5647-5651.
21. Muskett J. C., Reed N. E., Thornton D. H. Increased virulence of an infectious bursal disease live virus vaccine after passage in chicks. Vaccine. 3:1985;309-312.
22. Nazerian K., Dhawale S., Payne W. S. Structural proteins of two different plaque-size phenotype of fowlpox virus. Avian Dis. 33:1989;458-465.
23. Öppling V., Müller H., Becht H. Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus. Arch. Virol. 119:1991;211-223.
24. Reddy S. K., Sharma J. M., Ahmad J., Reddy D. N., McMillen J. K., Cook S. M., Wild M. A., Schwartz R. D. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine. 14:1996;469-477.
25. Richmond J. F. L., Lu S., Santoro J. C., Weng J., Hu S-L., Montefiori D. C., Robinson H. L. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 env antibody elicited by DNA priming and protein boosting. J. Virol. 72:1998;9092-9100.
26. Sakaguchi M., Nakamura H., Sonoda K., Okamura K., Yokogawa H., Matsuo K., Hirai K. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. Vaccine. 16:1998;472-479.
27. Sonoda K., Sakaguchi M., Okamura H., Yokogawa K., Hamada F., Hirai K. Expression of the NDV-F gene under the control of MDV1-gB promoter in recombinant MDV1. Silva R. F., Cheng H. H., Coussens P. M., Lee L. F., Velicer L. F. Proceeding of the 5th International Symposium on Marek's Disease. 1996;408-413 Rose Printing Co. Tallahassee.
28. Spies U., Müller H., Becht H. Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res. 8:1987;127-140.
29. Tsukamoto K., Tanimura N., Hihara H., Shirai J., Imai K., Nakamura K., Maeda M. Isolation of virulent infectious bursal disease virus from field outbreaks with high mortality in Japan. J. Vet. Med. Sci. 54:1992;153-155.
30. Tsukamoto K., Matsumura T., Mase M., Imai K. A highly sensitive, broad-spectrum infectivity assay for infectious bursal disease virus. Avian Dis. 39:1995a;575-586.
31. Tsukamoto K., Tanimura N., Kakita S., Ota K., Mase M., Imai K., Hihara H. Efficacy of three live vaccines against highly virulent infectious bursal disease virus and the optimum vaccination time. Avian Dis. 39:1995b;218-229.
32. Tsukamoto K., Kojima T., Komori Y., Tanimura N., Mase M., Yamaguchi S. Protection of chickens against very virulent Infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology. 257:1999;352-362.
33. Van Zijl M., Wensvoort G., Kluyver E. De, Hulst M., Van Der Gulden H., Gielkens A., Berns A., Moormann R. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65:1991;2761-2765.
34. Witter R. L., Lee L. F., Fadly A. M. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus. Avian Dis. 39:1995;269-284.
35. Yanagida N., Ogawa R., Li Y., Lee L. F., Nazerian K. Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 Gene of Marek's disease virus. J. Virol. 66:1992;1402-1408.
36. Yao K., Goodwin M. A., Vakharia V. N. Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J. Virol. 72:1998;2647-2654.